Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries
Dhruv Gupte, Nidhi Rashmikant Suthar, John K. MacDonald, Jessica Le, Ruben J. Colman, Brian G. Feagan, Camilyn Cheng, Jurij Hanzel, Christopher Ma, Vipul Jairath, Eileen Crowley · 2026
Read Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries by Dhruv Gupte, Nidhi Rashmikant Suthar, John K. MacDonald, Jessica Le, Ruben J. Colman, Brian G. Feagan, Camilyn Cheng, Jurij Hanzel, Christopher Ma, Vipul Jairath, Eileen Crowley (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624012.txt.
Description
Background and AimsDespite considerable advancements in the therapeutic landscape of inflammatory bowel disease (IBD) for adults, long delays exist for paediatric IBD (pIBD) approval, with a median delay of >7 years following adult approval. Our aim is to summarise the landscape of pIBD clinical trials through a review of trial registries.MethodsWe conducted a cross-sectional review of ClinicalTrials.gov and ClinicalTrialsRegister.
Catalog record
| CREATOR | Dhruv Gupte, Nidhi Rashmikant Suthar, John K. MacDonald, Jessica Le, Ruben J. Colman, Brian G. Feagan, Camilyn Cheng, Jurij Hanzel, Christopher Ma, Vipul Jairath, Eileen Crowley |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |